Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants
The nucleoside analog β-D-<i>N</i>4-hydroxycytidine is the active metabolite of the prodrug molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the RNA-dependent RNA polymerase (RdRp) enzyme, which is responsible for replicating the viral genome during the replic...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2023-02-01
|
| Edice: | Metabolites |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2218-1989/13/2/309 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|